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Abstract
In spite of evidence that domestic and wild birds may act as carriers of human pathogenic fungi, data on the role of laying hens as
reservoirs of drug resistant and virulent yeasts is lacking. Here, we assess several virulence factors (phospholipase and
haemolysin activity) and the antifungal susceptibility profiles of 84Candida albicans and 17 Candida catenulata strains isolated
from cloacae (group A), faeces (group B) and eggs (group C) of laying hens. Of these strains, 95% C. albicans and 23%
C. catenulata strains displayed phospholipase and haemolytic activities. For C. albicans, the highest values of phospholipase
(Pz = 0.62) and haemolytic activities (Hz = 0.49) were recorded among the strains from group C whilst for C. catenulata (Pz =
0.54; Hz = 0.49) among those from group A. High minimum inhibitory concentration (MIC) values for azoles and amphotericin
B (AmB) were recorded irrespective of their sources in all C. albicans strains. A total of 22 C. albicans strains were multidrug
resistant, displaying resistance to fluconazole, itraconazole (ITZ), voriconazole (VOR) and posaconazole (POS). All
C. catenulata strains from group C were resistant to ITZ, POS, micafungin and anidulafungin and susceptible to AmB. In this
study, C. albicans and C. catenulata isolated from the cloacae, faeces and eggs of laying hens produced phospholipase and
haemolysin and might be multidrug resistant. In the environment (faeces) or in eggs, C. albicans and C. catenulata strains might
acquire pathogenic virulence traits and/or show multidrug resistance profiles. Based on these results, breeding and handling of
laying hens and/or eggs may have implications for human and animal health.
Keywords Candida albicans .Candida catenulata . Laying hens . Virulence factors . Antifungal susceptibility
Introduction
Candida species are among the most common causes of in-
fections, with overwhelming mortality rates in immunocom-
promised patients (Antinori et al. 2018; Tscherner et al. 2019).
Candida spp. belong to the resident microbiota of the skin,
mucosa and gastrointestinal tract of mammals including
humans; in addition, domestic (Subramanya et al. 2017;
Cafarchia et al. 2018) and wild birds (Brilhante et al. 2010;
Brilhante et al. 2013) harbour and spread these yeasts in the
environment via their faeces (Brilhante et al. 2010; Elhariri
et al. 2015). Indeed, Candida albicans has been isolated from
the gut, cloaca and droppings of domestic (e.g. laying hens,
broiler chickens, pigeons) and wild (e.g. rhea, psittacinae, rap-
tors, cockatiels) birds (Subramanya et al. 2017; Cafarchia
et al. 2018; Brilhante et al. 2010). In addition, bird droppings
act as a suitable substrate for the growth of Candida spp. due
to intrinsically high concentrations of nitrogenous compounds
(Elhariri et al. 2015). Yeasts such as Candida, Cryptococcus,
Geotrichum, Rhodotorula and Trichosporon have also been
isolated from environment, avian sources and eggs (Cafarchia
et al. 2018). Interestingly, it has been demonstrated that laying
hens might disseminate yeasts, mainly C. albicans and
Candida catenulata, in the environment through eggs other
than faeces (Cafarchia et al. 2018). At present, there is a grow-
ing concern that these yeasts species might acquire virulence
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determinants and antimicrobial resistance when moving be-
tween different niches (Tsiodras et al. 2008). Virulence factors
such as secreted hydrolases (i.e. aspartyl proteases, phospho-
lipases and haemolysins) play a pivotal role in the pathogen-
esis of Candida spp. infections (GunTang et al. 2017); the
occurrence of such factors has been demonstrated in yeast
strains, mainly C. albicans, isolated from the gut, cloaca
and/or faeces of different avian species of synanthropic and
pet birds or poultry (Cafarchia et al. 2008; Sidrim et al. 2010).
Some of these yeasts also displayed a multidrug resistance
profile (Brilhante et al. 2013; Sidrim et al. 2010; Lord et al.
2010; Brilhante et al. 2011; Brilhante et al. 2012), which has
been associated, for fluconazole-resistance in particular, to the
secretion of phospholipases (Ying and Chunyang 2012). In
spite of the likely contribution of domestic and wild birds as
carriers of human pathogenic fungi, no data is yet available on
the role of laying hens as reservoirs of drug-resistant and vir-
ulent yeasts. Therefore, the present study aimed to assess (i)
the production of hydrolytic enzymes such as phospholipase
and haemolysin and (ii) the antifungal susceptibility profiles
of C. albicans and C. catenulata isolated from the cloacae,
faeces and eggs of laying hens.
Materials and methods
Fungal strains
A total of 101 strains of C. albicans (n = 84) and of
C. catenulata (n = 17), previously isolated from the cloacae,
faeces and eggs of laying hens (Cafarchia et al. 2018), were
employed in this study. In particular, two or three Candida
spp. strains per group in each positive shed were selected.
C. catenulata was chosen since it has also been isolated from
yolks and albumens of eggs (Cafarchia et al. 2018). The
strains were assigned to three groups based on their origin.
Group A included C. albicans (n = 67) and C. catenulata (n =
5) strains from cloacal swabs of laying hens; group B,
C. albicans (n = 13) and C. catenulata (n = 4) strains from
pools of faeces; and group C. C. albicans (n = 4) and
C. catenulata (n = 8) strains from egg samples. The strains
were isolated and identified based on colonial morphology,
microscopic features, and by matrix-assisted laser desorption/
ionisation time of flight mass spectrometry (MALDI-TOF
MS), as previously reported (Cafarchia et al. 2018). Strains
were stored at − 80 °C at the Department of Veterinary
Medicine, University of Bari (Italy). Prior to testing, each
strain was sub-cultured at least twice onto Sabouraud dextrose
agar (SDA, Liofilchem, Italy) plates at 30 °C for 24–48 h to
ensure strain purity and viability. All strains were molecularly
confirmed by amplification and sequencing of the nuclear
ribosomal ITS1-5.8S-ITS2 region.
In particular, genomic DNA was isolated from each strain
using the DNeasy Blood & Tissue Kit (QIAGEN, Hilden,
Germany), following manufacturer’s instructions. The nuclear
ribosomal ITS1-5.8S-ITS2 region was amplified using ITS1
(5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-TCCT
CCGCTTATTGATATGC-3′) primers. The PCR reaction
consisted of 4 μl genomic DNA (∼ 100 ng) and 46 μl of
PCR mix containing 2.5 mM MgCl2, 10 mM Tris-HCl (pH
8.3) and 50 mM KCl, 250 μM of each dNTP, 100 pmol of
each primer and 1.25 U of AmpliTaq Gold (Applied
Biosystems, Foster City, CA, USA), with an initial denatur-
ation step of 10 min at 95 °C, followed by 35 cycles of dena-
turation for 1 min at 95 °C, annealing for 45 s at 55 °C,
extension for 1 min 30 s at 72 °C and a final extension at 72
°C for 5 min. PCR products were examined on a 2% agarose
gel stained with GelRed (VWR International PBI, Milano,
Italy) and visualised on a Gel Logic 100 gel documentation
system (Kodak, New York, USA). The amplicons were puri-
fied and sequenced in both directions using the Big Dye
Terminator v.3.1 chemistry in a 3130 genetic analyser
(Applied Biosystems, CA, USA). Sequences were aligned
using the ClustalW program (Larkin et al. 2007) and com-
pared with those available in GenBank by basic local align-
ment search tool (BLAST—http://blast.ncbi.nlm.nih.gov/
Blast.cgi).
Preparation of the yeast suspensions for the
enzymatic activities
A loopful of the stock culture was streaked onto SDA and
incubated at 37 °C for 24–48 h. Colonies were transferred into
sterile saline solution and adjusted to an optical density of 1.3
using a turbidimeter (DEN-1McFarland Densitometer,
Biosan) that was equivalent to 1.5 × 107 CFU/ml as validated
by quantitative plate count of colony forming unit (CFU) in
SDA.
Phospholipase activity
The production of phospholipase for Candida spp. was
assessed using the egg-yolk plate method as previously de-
scribed (Cafarchia et al. 2008; Price et al. 1982). A total of
10 μl yeast suspension was transferred onto egg-yolk plates
and incubated at 32 °C for 5 days. The formation of a precip-
itation zone surrounding the colonies was considered as an
indicator for enzyme production. The production of phospho-
lipase (Pz) was expressed as a ratio of colony diameter by the
total diameter of the colonies plus zone of precipitation (Price
et al. 1982). Each strain was tested in duplicate, and the ex-
periments were repeated over two consecutive days. The Pz
values were reported as average of the values registered. The
following ranges of activity according to the Pz index were
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established as follows: high, Pz ≤ 0.69; moderate, Pz = 0.70–
0.89; weak, Pz = 0.90–0.99; none, Pz = 1 (Price et al. 1982).
Haemolytic activity
The haemolytic activity of Candida spp. was assessed by
using SDA supplemented with 7% sheep blood and 3% glu-
cose and adjusted to a pH of 5.6 ± 0.29. A total of 10 μl yeast
suspension was inoculated in duplicate onto the media and
incubated at 37 °C for 2 and 5 days, respectively. After incu-
bation, a distinct translucent halo around the inoculation site
indicated positive haemolytic activity (Elfeky and Gohar
2016). The ratio of the diameter of the colony (a) by that of
the translucent zone (b) was used as value of the haemolytic
index (Hz value) which represents the extent of haemolysin
activity by the different C. albicans strains tested. Each strain
was tested in duplicate, and the experiments were repeated
over two consecutive days. The Hz values were reported as
average of the values registered.
Antifungal susceptibility test
The sensitivity to antifungal drugs of C. albicans and
C. catenulata strains was evaluated using broth microdilution
(BMD) testing in accordance with the guidelines available in
the CLSI document M27-A3 (CLSI 2008). The following
antifungal drugs were supplied by the manufacturers as pure
standard compounds: amphotericin B (AmB) and itraconazole
(ITC) (Sigma-Aldrich Milan, Italy), fluconazole (FLC) and
voriconazole (VOR) (Pfizer Pharmaceuticals; Groton,
Connecticut, USA), posaconazole (POS) (Schering-Plough
Corporation, Kenilworth, NJ, USA), anidulafungin (ANI)
(Sigma-Aldrich, Milan, Italy) and micafungin (MCF)
(Sigma-Aldrich; Milan, Italy). FLC was dissolved in sterile
water, whereas the remaining drugs were solubilised in di-
methyl sulfoxide-DMSO (Sigma-Aldrich, Milan, Italy). The
concentration of each antifungal drug ranged from 0.016 to 32
mg/L, except for FLC (i.e. from 0.06 to 128 mg/L). Visual
reading of plates was performed after 48-h incubation at 35
°C. All strains were tested in duplicate. For azoles, the mini-
mum inhibitory concentration (MIC) endpoint was defined as
the lowest concentration that produced a significant decrease
in turbidity (≥ 50%) compared with that of drug-free control.
For AmB, the MIC endpoint was defined as the minimum
concentration at which no visible growth was detected.
Control strains (Candida parapsilosis ATCC 22019 and
Candida krusei ATCC 6258 of the American Type Culture
Collection, Manassas, VA, USA) were included to evaluate
the accuracy of drug dilutions and reproducibility of results
(CLSI 2008). Data were reported as MIC range, mean MIC
value (MICm) and MIC to which 50% (MIC50) and 90%
(MIC90) strains were inhibited. The following breakpoints
or epidemiological cut-off values (ECV) were used to
categorise these Candida strains as sensitive (S), dose-
dependent sensitive (SDD) or resistant (R) (Pfaller 2012a;
CLSI 2018): FLC (S MIC ≤ 2 μg/mL, SDD MIC = 4–32
μg/mL, R MIC ≥ 8 μg/mL); ITZ (S MIC = 0.125 μg/mL,
SDD MIC = 0.25–0.5 μg/mL, R MIC ≥ 1 μg/mL); POS
(ECV MIC ≤ 0.06 μg/mL, R MIC ≥ 0.06 μg/mL); VOR (S
MIC ≤ 0.125 μg/mL, SDDMIC = 0.25–0.5 μg/mL, R MIC ≥
μg/mL); MCF and ANI (S MIC ≤ 0. 25 μg/mL, SDD MIC =
0.5 μg/mL, R MIC ≥ 1 μg/mL) and AmB (ECV S MIC ≤ 2
μg/mL, R MIC > 2 μg /mL).
Statistical analyses
The Chi-square test (χ2) and the Student’s t test were used to
compare the virulence data, resistance occurrence and mean
MIC values of azoles, echinocandins, and AmB ofC. albicans
and C. catenulata from the three groups, respectively. A value
of P < 0.05 was considered statistically significant.
Results
The PCR assay produced species-specific bands of the expect-
ed size (550 bp) for bothC. albicans andC. catenulata strains,
and sequence analysis confirmed the initial identification,
based on colonial morphology, microscopic features and
MALDI identification as C. albicans (accession numbers:
KY101860, MH061333, MN419374) for 84 yeast isolates
and C. catenulata (accession number: KY103373) for 17
yeast isolates.
A total of 80 C. albicans (95%) and 4 C. catenulata (23.5
%) strains showed phospholipase and haemolytic activities
that differed according to the sample source, with the highest
values recorded for C. albicans (Pz = 0.62, Hz = 0.49) in
strains from group C and for C. catenulata (Pz = 0.54; Hz =
0.49) in strains from group A (Table 1).
High MIC values for azoles and AmB were recorded in all
C. albicans strains from groups B and C (Table 2).
C. catenulata showed high ITZ, POS ad VOR MIC values
in strains from group B (faeces). ANI and MCF displayed the
lowest MICs for bothC. albicans and C. catenulata (Table 2).
ForC. catenulata, highMIC values for MCF (MIC 90 = 8) and
ANI (MIC 90 = 8) were registered in strains from group C.
A relatively large number of C. albicans strains from
groups B and C were resistant to azoles (i.e. from 30.7% for
VOR to 92.3 % for POS in group B and from 50 to 100% for
all azoles in group C). MCF resistance was observed in C
albicans strains from group A (6%) and group C (50%)
(Table 3). The drugs with the highest number of resistant
C. albicans strains was POS (i.e. 83.6% strains in group A,
100% strains in groups B and C) followed by FLZ and ITZ
(Table 3). All C. albicans strains were susceptible to ANI and
AmB. A total of 21 C. albicans strains (15 from group A, 4
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from group B and 2 from group C) were multidrug resistant,
displaying resistance to FLC, ITZ, VOR, and POS. All
C. catenulata strains from the group C were resistant to
FLZ, ITZ, POS, MCF and ANI but susceptible to AmB
(Table 3). C. catenulata strains from group A (40%) and
group B (25%) were resistant to AmB.
Discussion
The results of this study demonstrate that C. albicans and
C. catenulata isolated from cloacae, faeces and eggs of laying
hens produce phospholipase and haemolysin and are resistant
to azoles or AmB and echinocandin, thus highlighting the role
Table 2 Minimum inhibitory concentration (MIC, μg /mL) for the antifungal drugs tested of Candida albicans and Candida catenulata isolated from
cloacal swabs (group A), faeces (group B) and eggs (group C) of laying hens
Groups Antifungal agents Candida albicans Candida catenulata
Range MIC50 MIC 90 MIC m (dev.st) Range MIC50 MIC 90 MIC m (dev.st)
Group A: cloacal swab FLC 0.008-128 0.25 128 33.8 (55.4) 4–128 8 8 31.2 (54.1)e
ITZ 0.06–32 0.25 32 7.6 (12.9) 0.25–32 0.5 1 6.9 (14.0)
VOR 0.06–32 0.015 32 7.5 (13.1) 0.03–32 0.06 0.125 6.4 (14.2)
POS 0.03–32 0.125 32 7.2 (12.7) 0.032–32 0.5 0.5 6.7 (14.1)
MCF 0.03–1 0.03 0.125 0.1 (0.2)a 0.016–0.125 0.032 0.125 0.07 (0.05)
ANI 0.03–0.5 0.06 0.5 0.1 (0.1)c 0.016–0.25 0.06 0.25 0.1 (0.1)h
AmB 0.016–2 1 1 1.3 (0.5) 0.5–2 0.5 2 1.2 (0.75)
Group B: faeces FLC 0.25–128 8 128 52.9 (61.8) 4–128 8 128 67 (70.4)e
ITZ 0.25–32 1 32 10.3 (15.1) 0.25–32 0.5 32 16.1 (18.2)
VOR 0.03–32 0.125 32 9.9 (15.3) 0.125–32 16 32 20.0 (15.2)f
POS 0.06–32 0.5 32 7.6 (13.9) 0.5–32 16 32 20.1 (15.1)g
MCF 0.03–0.125 0.06 0.125 0.06 (0.04)b 0.016–32 0.016 0.03 0.2 (0.4)
ANI 0.03–0.125 0.125 0.25 0.1 (0.1)d 0.06–0.5 0.06 0.06 0.1 (0.2)i
AmB 0.125–2 1 2 1.2 (0.6) 1–2 1 1 1.2 (0.5)k
Group C: eggs FLC 4–128 128 128 67 (70.4) 8–32 32 32 19 (11.3)
ITZ 0.25–16 16 16 8.3 (8.8) 1–8 2 8 3.8 (3.4)
VOR 0.03–16 16 16 8.0 (9.2) 0.06–2 0.125 0.25 0.3 (0.7)f
POS 0.125–16 16 16 8.1 (9.1) 1–4 2 4 2.6 (1.2)g
MCF 0.06–2 2 2 1.0 (1.1)ab 2–16 2 8 4.7 (5.0)
ANI 0.25–0.5 0.25 0.25 0.3 (0.1)cd 1–8 4 8 3.6 (2.1)h,i
AmB 0.5–2 0.5 0.5 0.8 (0.8) 0.5–1 0.5 1 0.68 (0.3)k
FLC, fluconazole; ITZ, itraconazole; VOR, voriconazole; POS, posaconazole; MCF, micafungin; ANI, anidulafungin; AmB, amphotericin. The
statistically significant differences were reported with the same superscript letter
Table 1 Phospholipase activity and haemolysin activity of Candida albicans and Candida catenulata strains from cloaca swabs (group A), faeces
(group B) and eggs (group C)
Group Candida albicans Candida catenulata
Phospholipase Haemolysin Phospholipase Haemolysin
Number of
isolates (%)
Mean Pz (sd) Number of
isolates (%)
Mean Hz (sd) Number of
isolates (%)
Mean Pz (sd) Number of
isolates (%)
Mean Hz (sd)
Group A 65/67(97.0) 0.65 (0.11)a, b 66/67 (98.5) 0.58 (0.12) 5/5 (100) 0.54 (0.03)d 2/5 (40) 0.49 (0.001)e
Group B 11/13 (84.6) 0.73 (0.03)a 11/13 (84.6) 0.52 (0.08) 2/4 (50) 0.72 (0.03)d 24 (50) 0.59 (0.002)e
Group C 3/4 (75.0) 0.62 (0.12)b 4/4 (100) 0.49 (0.02) 1/8 (12.5) 0.67 (0.04)d 0/8 (0) 0e
Total 80/84 (95. 2) 0.66 (0.05) 81/84 (96.4) 0.53 (0.04) 8/17 (47) 0.64 (0.09) 4/17 (23.5) 0.54 (0.07)
sd, standard deviation; the statistically significant differences were reported with the same superscript letters
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of laying hens in harbouring and spreading pathogenic organ-
isms in the environment. This finding is similar to that previ-
ously reported for strains from wild (Brilhante et al. 2013;
Lord et al. 2010) or domesticated/pet birds (Subramanya
et al. 2017; Ying and Chunyang 2012).
The production of phospholipase and proteinase has been
shown to play a significant role in the pathogenesis and viru-
lence of Candida species and related diseases (Dabiri et al.
2018). In addition, multidrug resistant yeasts often cause fatal
infection in immunocompromised hosts (Mellinghoff et al.
2018). In this study, the virulence, azoles and echinocandins
resistance profiles of yeasts varied according to the origin of
Candida spp. In particular, forC. albicans, multidrug resistant
strains were all isolated from the cloacae, faeces and eggs of
laying hens, thus suggesting that the cloaca is the most likely
source of multidrug resistance strains that are spread in the
environment via the faeces or food. Resistance to azole deriv-
atives is linked to changes in gene sequence or expression and
appears to be linked to selective pressures induced by expo-
sure to the azole products used in clinical practice or in agri-
culture (Brilhante et al. 2013; Brilhante et al. 2012; Pfaller
2012b). Since the animals from this study had no history of
previous treatment with antifungal drugs, the drug-resistance
detected in this study might be associated with the presence of
these compounds in the feed or fruits administered to these
animals, in accordance with previous reports (Subramanya
et al. 2017; Brilhante et al. 2010; Brilhante et al. 2013).
Long-term laboratory maintenance of microorganisms might
influence the expression of some virulence factors; neverthe-
less, in this study, we observed that the virulence of Candida
strains varied according to sample origin. In particular, the
phospholipase and haemolytic activities of C. albicans were
higher in strains isolated from eggs than those cloaca isolated
ones. This finding might be linked to the extracellular
enzymes secreted by C. albicans that might vary according
to different host factors associated to the ecosystem within
which the yeast resides (Gil-Bona et al. 2018). Thus,
C. albicans might acquire virulence traits when in the envi-
ronment or/and in eggs. For C. catenulata, the presence of
drug resistance phenomena was most frequently observed
among strains isolated from eggs. This finding might be due
to a positive selection of the environment on the multidrug
resistance of C. catenulata strains (Sidrim et al. 2010).
However, C. catenulata strains from eggs are less able to
produce phospholipase or protease, thus indicating a lower
pathogenicity compared with the strains isolated from cloaca
and suggesting a lower risk of human or animal infections
posed from strains from the environment. Indeed,
C. catenulata is a natural contaminant of dairy products but
is nonetheless rarely associated with invasive or skin infection
in human (Crozier and Coats 1977; Sârbu et al. 2013; Çakır
et al. 2019; Ha et al. 2018; Radosavljevic et al. 1999).
In particular, even if > 106C. catenulataCFU/gr have been
detected in Australian Camembert or other European cheese
(Roostita 1996), the yeast was identified as the causative agent
in onychomycosis or vulvovaginal infections and in only three
cases of candidaemia (i.e. in one patient with gastric cancer, in
one hospitalised premature infant and in one cirrhotic patient
with endocarditis) (Crozier and Coats 1977; Sârbu et al. 2013;
Çakır et al. 2019; Ha et al. 2018; Radosavljevic et al. 1999).
However, even if C. catenulata is less pathogenic than
C. albicans, its high distribution and low susceptibility to
ITZ, POS, MCF and ANI as well as AmB might require a
specific therapeutic protocol. A case ofC. catenulata invasive
infection was reported in a cancer patient that was successfully
treated with intravenous AmB, following failed FLZ treatment
(Radosavljevic et al. 1999). Nosocomial infections caused by
Candida spp. have becomemore common in recent years, and
Table 3 Candida albicans and Candida catenulata strains isolated from cloacal swabs (group A), faeces (group B) and eggs (Group C) of laying hens
that are resistant to at least one of the antifungal drugs tested
Antifungal agents Group A: cloacal swab Group B: pool of faeces Group C: eggs
Number of isolates (%) Number of isolates (%) Number of isolates (%)
C. albicans C. catenulata C. albicans C. catenulata C. albicans C. catenulate
FLC 24/67 (35.8%)a 4/5 (80%) 10/13(76.9%)a 3/4 (75%) 3/4 (75%) 8/8 (100%)
ITZ 25/67 (37.3%) 3/5 (60%) 7/13 (53.8) 2/4 (50%) 3/4 (75%) 8/8 (100%)
VOR 18/67 (26.8%) 1/5 (20%) 4/13 (30.7) 1/4 (25%) 2/4 (50%) 1/8 (12.5%)
POS 56/67 (83.6%) 4/5 (80%) 12/13 (92.3%) 4/4 (100%) 4/4 (100%) 8/8 (100%)
MCF 4/67 (6%)b 0/5 (0%) 0/13 (0%) 1/4 (25%) 2/4 (50%)b 8/8 (100%)
ANI 0/67 (0%) 0/5 (0%) 0/13 (0%) 0/4 (0%) 0/4 (0%) 8/8 (100%)
AmB 0/67 (0%) 2/5 (40%) 0/13 (0%) 1/4 (25%) 0/4 (0%) 0/8 (0%)
FLC, fluconazole; ITZ, itraconazole; VOR, voriconazole; POS, posaconazole; MCF, micafungin; ANI, anidulafungin; AmB, amphotericin. The
statistically significant differences were reported with the same superscript letter
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those caused by non-albicans Candida spp. are rising propor-
tionally more than those by C. albicans, being responsible for
35–65% of all candidaemia in the general patient population
(Sharma et al. 2017). Food or beverages may act as sources of
Candida spp. infection that, following ingestion, might enter
the bloodstream and cause fungaemia (Benedict et al. 2016).
Although clinical cases are rare and occur in unusual clinical
circumstances, the presence of yeasts in food may be of sig-
nificance. In the environment (faeces) or in eggs, C. albicans
strains are more pathogenic and are characterised by protease
and haemolysin production and azole resistance, whereas
C. catenulata is characterised by a multidrug resistance pro-
file. Interestingly, the high MIC values for AmB detected
among C. albicans from faeces or eggs and in C. catenulata
from cloaca swabs are in contrast with those previously re-
ported for yeasts isolated from Agapornis birds and cockatiels
that are bred under different conditions (Brilhante et al. 2010;
Reis et al. 2018).
However, despite the high MIC values registered for
AmB, resistance phenomena were detected only in
C. catenulata from groups A and B, most likely due
to the high value of ECV used (i.e. MIC > 2) or to
the small number of samples tested. Since AmB and
echinocandins are the first line of treatment for
Candida fungaemia (Keane et al. 2018; Demir et al.
2019), resistance to these drugs should be not
underestimated and needs to be further investigated
using molecular approaches. The co-habitation of
humans and laying hens and/or eggs may expose
humans to multidrug-resistant and virulent yeasts. The
breeding and handling of these animals may have con-
sequently substantial implications for human and animal
health. Therefore, high hygiene procedures in laying
hens farm as well as the use of personal protective
equipment might be important to prevent human
(keepers/or visiting) and bird exposure to infectious
propagules contaminating the environment and the eggs.
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